Revolution Medicines (RVMD) Deferred Taxes (2019 - 2024)
Revolution Medicines (RVMD) posted quarterly Deferred Taxes of $762000.0 for Q4 2024, up 1672.09% year-over-year from $43000.0 in Q1 2024, and up 1672.09% quarter-over-quarter from $43000.0 in Q4 2023.
Revolution Medicines (RVMD) Deferred Taxes (2019 - 2024) Analysis & Trends
Revolution Medicines' Deferred Taxes history runs 5 years deep, the most recent figure standing at $762000.0 for Q4 2024.
- In Q4 2024, Deferred Taxes rose 1672.09% year-over-year to $762000.0; the TTM figure through Dec 2024 stood at $928000.0 (up 580.83% YoY), while the FY2024 annual figure was $762000.0, down 80.51% from the prior year.
- Deferred Taxes for Q4 2024 stood at $762000.0, up from $43000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $762000.0 in Q4 2024, with the low at -$359000.0 in Q4 2020.
- The 4-year median for Deferred Taxes is $83000.0 (2022), against an average of $217166.7.
- The sharpest annual moves came in 2020 and 2024: Deferred Taxes tumbled 107.56% in 2020, then jumped 1672.09% in 2024.
- Revolution Medicines' Deferred Taxes stood at -$359000.0 in 2020, then jumped by 134.26% to $123000.0 in 2022, then plunged by 65.04% to $43000.0 in 2023, then surged by 1672.09% to $762000.0 in 2024.
- Business Quant data shows RVMD's Deferred Taxes at $762000.0 in Q4 2024, $43000.0 in Q4 2023, and $123000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 762,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Dec 31, 2020 | -359,000.00 |
| Jun 30, 2020 | 18,000.00 |
| Mar 31, 2020 | 716,000.00 |
| Dec 31, 2019 | 4.75 Mn |
| Sep 30, 2019 | -141,000.00 |
| Jun 30, 2019 | -136,000.00 |
| Mar 31, 2019 | -96,000.00 |